CD274 and cancer: A number of studies investigating PD-(L)1 inhibition in recurrent or metastatic HPV-associated OPSCC after progression on platinum-based regimens report numerically improved response rates or overall survival for HPV-associated cancers compared to HPV-negative cancers [74,75,76,77,78].